U.S. Senate · 118th Congress · S. 5271
BUPE for Recovery Act
A bill to require the Administrator of the Drug Enforcement Administration to temporarily exempt buprenorphine from the Suspicious Orders Report System for the remainder of the opioid public health emergency.
Follow
Log in to follow this bill and get an email when there’s a new vote (premium).
- Sponsor
- Martin HeinrichD-NM
- Introduced
- September 25, 2024, in the Senate
- Issue areas
- Policy area
- Health (from the Congressional Research Service)
- Full text and actions
- congress.gov
Votes on this bill (0)
Neither the House nor the Senate has held a roll-call vote on this bill.
Cosponsors (0)
No member has cosponsored this bill.